11C-choline has been used in the diagnosis and follow-up of patients with prostate cancer for years.
Choline PET/CT has been available in human care since March, 2014 in our country. Unfortunately this examination has not been reimbursed by the National Health Insurance so far. We retrospectively analysed and assessed the results of 40 patients who underwent 11C-choline PET/CT on the basis of previous literature. As our study group was heterogeneous statistical analysis was not performed.
Garai I, Farkas B, Oszlánszki A, Berczi C, Flaskó T, Galuska L. Are you the author?
ScanoMed Nukleáris Medicina Oktató és Kutató Kft., Debrecen, Hungary; Nukleáris Medicina Intézet, Debreceni Egyetem, Debrecen, Hungary; Urológiai Klinika, Debreceni Egyetem, Debrecen, Hungary.
Reference: Magy Onkol. 2015 Mar;59(1):25-9.
Article in Hungarian.